A Tramutola

First name:
A
Last name:
Tramutola
Tramutola, A., Lanzillotta, C., Di Domenico, F., Head, E., Butterfield, D. A., Perluigi, M., & Barone, E. (2020). Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome. Neurobiology Of Disease, 137, 104772. https://doi.org/10.1016/j.nbd.2020.104772
View
Tramutola, A., Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., et al. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype. Journal Of Alzheimer's Disease : Jad, 52(1), 359-371. https://doi.org/10.3233/JAD-151105 (Original work published 2016)
View
Tramutola, A., Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease. Oxidative Medicine And Cellular Longevity, 2016, 2756068. https://doi.org/10.1155/2016/2756068 (Original work published 2016)
View
Barone, E., Di Domenico, F., Cassano, T., Arena, A., Tramutola, A., Lavecchia, M. A., et al. (2016). Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. Free Radical Biology & Medicine, 91, 127-42. https://doi.org/10.1016/j.freeradbiomed.2015.12.012
View
Di Domenico, F., Tramutola, A., & Butterfield, D. A. (2017). Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders. Free Radical Biology & Medicine, 111, 253-261. https://doi.org/10.1016/j.freeradbiomed.2016.10.490
View
Tramutola, A., Arena, A., Cini, C., Butterfield, D. A., & Barone, E. (2017). Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Expert Review Of Neurotherapeutics, 17(1), 59-75. https://doi.org/10.1080/14737175.2017.1246183
View
Tramutola, A., Di Domenico, F., Barone, E., Arena, A., Giorgi, A., di Francesco, L., et al. (2017). Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology. Antioxidants & Redox Signaling, 26(7), 280-298. https://doi.org/10.1089/ars.2016.6686 (Original work published 2017)
View
Perluigi, M., Picca, A., Montanari, E., Calvani, R., Marini, F., Matassa, R., et al. (2022). Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles. Alzheimer's & Dementia : The Journal Of The Alzheimer's Association, 18(8), 1498-1510. https://doi.org/10.1002/alz.12499
View
Lanzillotta, C., Tramutola, A., Di Giacomo, G., Marini, F., Butterfield, D. A., Di Domenico, F., et al. (2021). Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome. Free Radical Biology & Medicine, 165, 152-170. https://doi.org/10.1016/j.freeradbiomed.2021.01.042
View
Perluigi, M., Tramutola, A., Pagnotta, S., Barone, E., & Butterfield, D. A. (2020). The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia. Antioxidants (Basel, Switzerland), 9(9). https://doi.org/10.3390/antiox9090779 (Original work published 2020)
View